New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 22, 2013
10:00 EDTBCEI, TTS, JIVE, CR, USAC, ROLL, VRX, FANG, VSTM, OFG, PDCE, XOM, CVX, BRCMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Broadcom (BRCM) initiated with an Overweight at Piper Jaffray... Chevron (CVX) initiated with a Buy at Canaccord... Exxon Mobil (XOM) initiated with a Hold at Canaccord... Oriental Financial (OFG) initiated with a Buy at Jefferies... PDC Energy (PDCE) initiated with an Outperform at Iberia... Verastem (VSTM) initiated with a Buy at Guggenheim... Valeant (VRX) initiated with a Buy at Aegis... Diamondback Energy (FANG) initiated with a Buy at Brean Capital... USA Compression (USAC) initiated with an Outperform at Raymond James... RBC Bearings (ROLL) reinstated with a Buy at BofA/Merrill... Crane (CR) initiated with a Buy at Ascendiant Capital... Tile Shop (TTS) initiated with an Outperform at Wedbush... Jive Software (JIVE) initiated with an Outperform at Northland Securities... Bonanza Creek (BCEI) initiated with a Buy at Brean Capital.
News For BRCM;CVX;XOM;PDCE;OFG;VSTM;FANG;VRX;ROLL;USAC;CR;JIVE;TTS;BCEI From The Last 14 Days
Check below for free stories on BRCM;CVX;XOM;PDCE;OFG;VSTM;FANG;VRX;ROLL;USAC;CR;JIVE;TTS;BCEI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 15, 2014
20:02 EDTCVXConocoPhillips auctioning 24% stake in the Clair oilfield, FT reports
ConocoPhillips (COP) has hired banks to sell its 24% stake in UK's largest oilfield, The Financial Times reports, citing people familiar with the matter. The 24% stake could be valued between $2B-$3B, the people added. The Clair oilfield sits in Scottish territorial waters, and Conoco's interest in exiting the project is a sign of the challenges facing the North Sea oil industry, The Financial Times added. BP (BP) operates the Clair oilfield and owns a 28.6% stake, Royal Dutch Shell (RDS.A) controls a 28.6% stake, and Chevron (CVX) controls a 19% stake. Reference Link
07:02 EDTCVXMcDermott completes contract scope for Jack, St. Malo project
Subscribe for More Information
06:29 EDTCVXChevron pipeline shut down following accident that killed one, WSJ reports
Subscribe for More Information
September 12, 2014
14:03 EDTBRCMKeysight enters into manufacturing test license agreement with Broadcom
Subscribe for More Information
11:49 EDTCVXChevron CEO looks for partner before Kitimat project decision, Bloomberg says
Chevron CEO John Watson said that the firm needs to locate a partner, finalize natural gas contracts and examine engineering expenses prior to making a choice regarding its Canadian liquefied natural gas project in Kitimat, according to Bloomberg, citing comments from Watson. Reference Link
08:02 EDTVRXPershing submits special meeting requests totaling 35% of Allergan shares
Subscribe for More Information
07:28 EDTXOMExxon Mobil at risk from sanctions on Russia, WSJ says
New sanctions enacted by the U.S. and the EU against Russia over the ongoing conflict in Ukraine threaten one of Exxon Mobil's best chances to find and tap significant amounts of crude oil via its partnership with Russia's state-owned oil company OAO Rosneft, said The Wall Street Journal. A U.S. official said the new sanctions would affect Exxon's current drilling in the Kara Sea with Rosneft, though the extent of the impact was unclear, the Journal added. Reference Link
05:34 EDTBRCMRovi announces collaboration with Broadcom
Subscribe for More Information
05:09 EDTVRXAllergan comments on Pershing Square delivery of additional requests
Allergan (AGN) commented on Pershing Square Capital Management delivery of additional requests from stockholders owning 1.5% of Allerganís shares to call a Special Meeting of Stockholders. Allergan will review these requests in addition to the requests from stockholders owning 2.8% of Allerganís shares that were delivered on September 3. The company issued the following statement: Notwithstanding Pershing Square and Valeant Pharmaceuticals (VRX) efforts to change the subject, Allergan recognizes that what actually matters is value, and thatís what the company is focusing on delivering to stockholders. In that regard, Allerganís current strategic plan is expected to deliver a compounded annual growth rate of greater than 20% EPS growth, including estimated 2016 EPS at approximately $10.00. Allergan has already scheduled the Special Meeting for December 18. As such, the delivery of additional requests for the Special Meeting by Pershing Square is not a meaningful development. The lawsuit in California is seeking an order barring Valeant, Pershing Square, Ackman, and entities affiliated with them from voting shares that Allergan believes were acquired in violation of the federal securities laws, including insider trading. If Allerganís motion for a preliminary injunction is granted, it would prevent Valeant, Pershing Square, and Ackman from voting their shares at any meeting of stockholders.
September 11, 2014
17:27 EDTBRCMBroadcom powers new TiVo Ultra HD set-top box solution
Subscribe for More Information
09:52 EDTVRXValeant to submit consent from 35% of Allergan holders, CNBC reports
Subscribe for More Information
September 10, 2014
08:22 EDTCVX, XOMBofA/Merrill oil and gas analysts hold an analyst/industry conference call
Subscribe for More Information
08:12 EDTBRCMApple iPhone 802.11ac support a positve for Broadcom, says Macquarie
Subscribe for More Information
September 9, 2014
10:10 EDTCVXOn the Fly: Analyst Downgrade Summary
Subscribe for More Information
07:40 EDTCVXChevron downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
07:10 EDTCRGabelli to hold a conference
Subscribe for More Information
06:42 EDTVRXLew expects to make decision on combating inversion deals soon, NY Times reports
Subscribe for More Information
September 8, 2014
17:01 EDTVRXValeant to expand Bausch + Lomb facility, will add 120 new jobs
Valeant Pharmaceuticals announced that the company hosted a ribbon cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY. The ceremony recognized the expansion and installation of the new manufacturing lines, which will produce the company's silicone hydrogel contact lens, Bausch + Lomb ULTRA. The solar array, which is currently under construction, will generate and supply electricity through the installation of 3,667 solar panels, helping to reduce the Rochester facility's carbon footprint by 800 tons of carbon dioxide emissions annually.
10:06 EDTBCEIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:44 EDTBCEIBonanza Creek downgraded to Outperform from Strong Buy at Raymond James
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use